Načítá se...
Doxycycline as a potential partner of COVID-19 therapies
Coronavirus disease 2019 (COVID-19) is a major public health challenge, and the current antiviral arsenal for treatment is limited, with questionable efficacy. Major efforts are under way for discovery of new effective agents, but the validation of new potential treatments for COVID-19 may take a lo...
Uloženo v:
| Vydáno v: | IDCases |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7298522/ https://ncbi.nlm.nih.gov/pubmed/32566483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.idcr.2020.e00864 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|